logo

Tag : Commoditization

Differentiation Through Content

Your content is a product. Differentiate it.All of us life science marketers know that we need to differentiate our products and services. Nothing new there. It’s critical to demonstrate a unique value and avoid commoditization. But how often do you think about how well differentiated your content is? My experience has shown me that for most of you the answer will be: never.

Marketers often think of their content as something which is a carrot for the customer; something that is of benefit to them and for their own good. You’re providing them with knowledge so they should just eat it up and be grateful for it. Unfortunately that viewpoint is completely misaligned with reality.

Your Content is a Product

Your audiences are customers of your content. They are paying for your content with their time and, if you require them to fill out a form, paying for it with their contact information as well. All the same rules apply to your content as apply to your products. Your content has to be worth the “price”. You need to effectively “sell” it.

Your content also needs to be differentiated. Without differentiation, your content will be just one in a never-ending stream of content pieces being continuously created. And unlike with products, your content can’t compete on price. Your content either provides unique value or it won’t be consumed by your audience. Even worse, they might consume then resent you for wasting their time.

Ways to Differentiate Content

The best and most obvious way to differentiate your content is to say something different from what everyone else is saying. Take a stance on a topic and deliver content that has particular value for your target market segment. Demonstrate your existing position(s) through content. Not only will you be reinforcing your positioning, but so long as your position is unique your content will be inherently unique as well. Content which is differentiated in this manner will help drive your target market segment towards you while driving away the off-target audiences which would eat up time and resources but ultimately not become customers.

Some other ways to differentiate content include:

  • Find an area where you have knowledge that can’t readily be found elsewhere and share it. This can also help reinforce your positioning.
  • Forego traditional content and instead develop resources that help solve customer problems. There’s huge brand and customer experience advantages to be claimed in doing so.
  • Create content in different formats. If your competition are flooding the space with white papers, do a video or a webinar. Different people have different preferences for content.
  • Drill down or add a twist. If something has already been said, get even more specific or put a spin on it in order to tailor it to a particular market segment.


Never forget that your content is a product, and like any product it risks commoditization if it is not differentiated. By differentiating your content, not only will you increase its effective audience and create more engagement with it, but you can reinforce your positioning and branding as well. Differentiated content is better for both you and your audience.

"Content marketing is a resource-intensive, time-consuming endeavor. Don’t let all that go to waste. Ensure your content is as effective as possible. Content marketing from BioBM can provide your company with the influence and reputation you need to turn purchasing decisions in your favor. Provide meaningful value to your customers, and they’ll provide value to you. It’s a virtuous cycle. Start yours."

Case: Content at a Small CRO

Content is an important sales support tool.It feels like every week I see or learn something that reinforces just how valuable content is to life science companies. For instance, I was recently discussing some sales dilemmas with the founder of a young, small CRO. Let’s call him Greg. Greg’s CRO performs a well-differentiated and valuable research service. However, Greg was lamenting about the “commoditization” of contract research – how his firm can’t seem to compete on quality and all anyone cares about is price.

Knowing what his CRO does, I was a bit disturbed by this. There are such things as commodities, sure, but the whole reason commodities become commoditized is because there is no difference in quality. Even coal fetches different prices based on, among other things, how clean it burns. If someone can mine better coal and get a better price for it, surely his CRO should be able to get a better price for their superior service. … I dug deeper.

Greg used a current problem he was having to illustrate his larger problem. He had drafted a proposal for his contact at a pharma company. That person reviewed his proposal, along with a number of others, then handed it to his boss to make a decision. According to Greg, the boss would then just choose one of the cheap ones.

Now there are times when budgets are tight and price is simply the most important factor, but this was a recurring problem. So what was really the big problem?

Greg’s CRO is young and small. He has built a rapport with his contact. He has not, however, built a rapport with the decision maker, which he does not have access to. So the person making the decision only knows Greg’s CRO from the information that is available about them on their website and with a quick internet search. This wouldn’t necessarily be a problem, but Greg’s CRO has no educational content. Unless the decision maker happens to know Greg or someone on his team, there is no reason for him to believe that they are capable of producing the higher-quality output they claim to be able to. Compared to the more established and lower cost CROs, selecting Greg’s CRO would be a high-risk endeavor!

To lower the perceived risk, and therefore increase the likelihood that their proposal is selected, Greg’s CRO needs to demonstrate their knowledge through content. Content can, at least to some extent, mitigate the inability to demonstrate knowledge through person-to-person content. It could help provide the confidence that may lack if Greg’s CRO cannot provide many reputable customer references. Instead of only knowing Greg’s CRO as a proposal, at least they would be able to build some degree of positive brand image.

Content is an extremely multifunctional marketing tool that can assist organizations in numerous ways. Content can aid in sales support, as with the case of this CRO, it can generate leads, it can help drive inbound search traffic, it can improve your brand. There’s so much that content can do, and it contributes to so many aspects of marketing, that content marketing should really be a default. Especially in knowledge-intensive sectors like contract research and life science tools, content should be a centerpiece of the marketing effort for most companies. Content marketing is simply too valuable, and valuable in too many situations, to ignore.

What do you think?

What would you do if you were Greg? Would you invest in content marketing? Would you take another approach? Join the discussion on LinkedIn and share your thoughts.

Marketing of Life Science Tools & Services

"Is content the centerpiece of your marketing effort? If it’s not, or if you’re not sure what you need to do to craft high-value, multifunctional content, contact us. We’ll put you on the path to more leads, improved conversion, and more effective overall marketing – with content at the center."

Defend Against Commoditization

Commoditization – the transformation of goods and services into a commodity – is a major problem when it threatens to rear it’s head. As technologies age, lose patent protection and become less expensive, there are often more competitors that will join the market. For many areas of the research products market, the eventual threat of commoditization is almost an inevitability. This is particularly true with reagents, chemicals, low-end equipment, plasticware, and glassware, but is also readily apparent in the market for kits and some kinds of proteins and antibodies. If these products lack a qualitative differentiator, they will all eventually become commodities. As such, customers will seek out only the lowest price goods and profit margins will take a huge hit. However, such is not always the case. In many of these markets there is still one factor that can make a huge difference. There is one way to add perceived value and differentiate your product from the commodities: branding.

When I use branding in this sense, I don’t simply mean some flashy marketing and design that contributes to brand or product recognition. Branding must mean the entire value that is behind the brand, including quality, customer service and support. Indeed, quality, customer service, and support are the things least likely to be replicated by competitors looking to sell low-price products. So then why are these things not the “one way to add perceived value”? Simple – all of these things get expressed through the brand.

Let’s take plasticware as an example. Eppendorf has an enormous share of the microtube market, and not for lack of competition. There are literally dozens of manufacturers of microcentrifuge tubes, and most microtubes are far cheaper than Eppendorf’s. So then why does Eppendorf maintain such a huge share of what should, at a glance, be a commodity? Entrenchment and longstanding brand recognition aside, they have an extremely high quality product (and I would know – I’ve put all sorts of microtubes through the gauntlet in my day), and that quality is consistent. This is then captured through the brand. People see the Eppendorf branding on a product and presume, usually rightfully, that they can trust it’s quality. Many other manufacturers who are trying to undercut Eppendorf are not able to replicate their quality at such a low price, so Eppendorf maintains the advantage of pricing its product higher due to the differentiation created by the higher quality product and expressed through the brand.

Another great example shines out in the Life Technologies 2010 Q2 earnings conference call question & answer session. Jonathan Groberg of Macquarie Research asked about Life Technologies’ PCR portfolio and commoditization in the PCR market. Gregory Lucier, Life Technologies’ CEO and Chairman, responded by saying:

…the relationship between price and volume is not a direct connection. And that’s due to a lot of the friction of publications, previous experiments. There’s just inertia to switching. And when you have market leadership like we certainly do in the PCR business, people are inclined to stay with their products, and so we benefited from that.

Again, this is a non-tangible perceived value addition. Life Technologies is attributing the continued success of its PCR line in part of the value that the brand conveys – in this case a “tried and tested” product. Scientists know that everyone uses Life Technologies PCR products, and they therefore trust them to be reliable.

If you’re on the outside of a bioscience market where commoditization is either already present or a serious risk and you’re trying to get in, or if you have a small market share and a brand with little recognition, these examples admittedly may not seem too helpful to you. While market entry is a topic large enough for a lengthy book, I will offer a few tips as they pertain to a partially or wholly commoditized market. 1) Look at your entrenched competition and use them as a baseline. What are they doing that allows them to avoid commoditization where everyone else fails? Can you position yourself to have an advantage other than price? Evaluate the hurdles that need to be overcome to do so. You can generally assume that your price point will need to be lower than the products of any well-known, entrenched marketplace behemoths (if they are present), but can be higher than the commoditized products. 2) Commoditized markets are most often very large (there’s an economic reason for this that I won’t get into) and trying to gain market entry across the entire market can often be too big of a task that dilutes marketing efforts and decreases marketing ROI. Find a particular sub-segment of the market that can be easily identified and marketed to and tackle that segment first. This strategy is almost always much more effective and gives you a foothold to expand your market share from.

Aging markets almost always lead to increased competition, but with a good marketing and business strategy, commoditization can be avoided.

"Are any of your products or the life science research markets they compete in at risk of commoditization? Want to form strategies for growing market share in a crowded marketplace with large amounts of competition? Need to develop a strong brand to fend off competition and establish your company as a market leader? BioBM’s expert business and marketing consultants are here to help you. Contact us to discuss your unique situation and learn how BioBM can help you maintain growth and profitability under pricing pressure and increasing competition."